These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 32760909)

  • 21. Investigation and correlation of physical stability, dissolution behaviour and interaction parameter of amorphous solid dispersions of telmisartan: a drug development perspective.
    Dukeck R; Sieger P; Karmwar P
    Eur J Pharm Sci; 2013 Jul; 49(4):723-31. PubMed ID: 23684913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial Drug Dissolution from Amorphous Solid Dispersions Controlled by Polymer Dissolution and Drug-Polymer Interaction.
    Chen Y; Wang S; Wang S; Liu C; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Pharm Res; 2016 Oct; 33(10):2445-58. PubMed ID: 27283830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural Modifications of Polyethylenimine to Control Drug Loading and Release Characteristics of Amorphous Solid Dispersions.
    Kelsall KN; Foroughi LM; Frank DS; Schenck L; LaBuda A; Matzger AJ
    Mol Pharm; 2023 Mar; 20(3):1779-1787. PubMed ID: 36719910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of stable amorphous solid dispersion and quantification of crystalline fraction of lopinavir by spectroscopic-chemometric methods.
    Hamed R; Mohamed EM; Sediri K; Khan MA; Rahman Z
    Int J Pharm; 2021 Jun; 602():120657. PubMed ID: 33930489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amorphous solid dispersion formation via solvent granulation - A case study with ritonavir and lopinavir.
    Trasi NS; Bhujbal S; Zhou QT; Taylor LS
    Int J Pharm X; 2019 Dec; 1():100035. PubMed ID: 31788669
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability and solubility enhancement of ellagic acid in cellulose ester solid dispersions.
    Li B; Harich K; Wegiel L; Taylor LS; Edgar KJ
    Carbohydr Polym; 2013 Feb; 92(2):1443-50. PubMed ID: 23399175
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multidrug, Anti-HIV Amorphous Solid Dispersions: Nature and Mechanisms of Impacts of Drugs on Each Other's Solution Concentrations.
    Arca HÇ; Mosquera-Giraldo LI; Dahal D; Taylor LS; Edgar KJ
    Mol Pharm; 2017 Nov; 14(11):3617-3627. PubMed ID: 28872867
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electromagnetic drop-on-demand (DoD) technology as an innovative platform for amorphous solid dispersion production.
    Helmy AM; Lu A; Duggal I; Rodrigues KP; Maniruzzaman M
    Int J Pharm; 2024 Jun; 658():124185. PubMed ID: 38703932
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thermodynamic and kinetic evaluation of the impact of polymer excipients on storage stability of amorphous itraconazole.
    Zhang S; Lee TWY; Chow AHL
    Int J Pharm; 2019 Jan; 555():394-403. PubMed ID: 30513399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amorphous Drug-Polymer Salt with High Stability under Tropical Conditions and Fast Dissolution: The Challenging Case of Lumefantrine-PAA.
    Yao X; Kim S; Gui Y; Chen Z; Yu J; Jones KJ; Yu L
    J Pharm Sci; 2021 Nov; 110(11):3670-3677. PubMed ID: 34371071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel supercritical carbon dioxide impregnation technique for the production of amorphous solid drug dispersions: a comparison to hot melt extrusion.
    Potter C; Tian Y; Walker G; McCoy C; Hornsby P; Donnelly C; Jones DS; Andrews GP
    Mol Pharm; 2015 May; 12(5):1377-90. PubMed ID: 25730138
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combining amorphous solid dispersions for improved kinetic solubility of posaconazole simultaneously released from soluble PVP/VA64 and an insoluble ammonio methacrylate copolymer.
    Danda LJA; Batista LM; Melo VCS; Soares Sobrinho JL; Soares MFR
    Eur J Pharm Sci; 2019 May; 133():79-85. PubMed ID: 30890364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of Temperature and Moisture on the Physical Stability of Binary and Ternary Amorphous Solid Dispersions of Celecoxib.
    Xie T; Taylor LS
    J Pharm Sci; 2017 Jan; 106(1):100-110. PubMed ID: 27476771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interplay of degradation, dissolution and stabilization of clarithromycin and its amorphous solid dispersions.
    Pereira JM; Mejia-Ariza R; Ilevbare GA; McGettigan HE; Sriranganathan N; Taylor LS; Davis RM; Edgar KJ
    Mol Pharm; 2013 Dec; 10(12):4640-53. PubMed ID: 24116899
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
    Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
    Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improved dissolution of an enteric polymer and its amorphous solid dispersions by polymer salt formation.
    Qi Q; Taylor LS
    Int J Pharm; 2022 Jun; 622():121886. PubMed ID: 35661745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions.
    Chen Y; Liu C; Chen Z; Su C; Hageman M; Hussain M; Haskell R; Stefanski K; Qian F
    Mol Pharm; 2015 Feb; 12(2):576-89. PubMed ID: 25535667
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microstructure Formation for Improved Dissolution Performance of Lopinavir Amorphous Solid Dispersions.
    Li N; Taylor LS
    Mol Pharm; 2019 Apr; 16(4):1751-1765. PubMed ID: 30811205
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of hydrogen bonding between different crystallization tendency drugs and PVPVA on the stability of amorphous solid dispersions.
    Wu J; Mooter GVD
    Int J Pharm; 2023 Nov; 646():123440. PubMed ID: 37742824
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nanoscale Infrared, Thermal, and Mechanical Characterization of Telaprevir-Polymer Miscibility in Amorphous Solid Dispersions Prepared by Solvent Evaporation.
    Li N; Taylor LS
    Mol Pharm; 2016 Mar; 13(3):1123-36. PubMed ID: 26859046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.